I will try to ask her about it on Monday if I get a chance during live Q & A as I have already reached the pre-webinar questions limit.
Ph1a was done at CoH, JC then took control over current 1b to expand trial side locations. Maybe she underestimated the number of available neurosurgeons, hence the recent comments made by RM.
Would be a crappy situation to be in to, having a potential GBM cure but hardly anyone who can apply it. Like the early stage of EV roll out, huge demand and sales but only a few EV mechanics and EV charging locations.
But as always, sooner or later the market, in this case neurosurgeons / trial sides will catch up and adjust to the demand. Not to be underestimated, CHM 1101 is approved to be used in trials for children as well.
GLTA
CHM Price at posting:
1.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)